Viewing StudyNCT00004066



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004066
Status: COMPLETED
Last Update Posted: 2013-03-07
First Post: 1999-12-10

Brief Title: Gemcitabine Docetaxel and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Small Intestine Cancer
Ovarian Cancer
Sarcoma
Keywords:
Name View
stage IV adult soft tissue sarcoma View
adult leiomyosarcoma View
recurrent adult soft tissue sarcoma View
small intestine leiomyosarcoma View
stage IV uterine sarcoma View
recurrent uterine sarcoma View
uterine leiomyosarcoma View
ovarian sarcoma View
recurrent small intestine cancer View